Technetium-99m methoxyisobutylisonitrile chest imaging of small cell lung carcinoma: Relation to patient prognosis and chemotherapy response - A preliminary report

Cancer

Volumn 83, Issue 1, 1998, Pages 64-68

  Kao, Chia Hung ^a   ChangLai, Sheng Ping ^b   Chieng, Poon Ung ^c   Yen, Tzu Chen ^d  

^a TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^b CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^d CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Chemotherapy; Multidrug resistance mediated P glycoprotein; Small cell lung carcinoma; Technetium 99m methoxyisobutylisonitrile

Indexed keywords

CISPLATIN; ETOPOSIDE; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG RESPONSE; HUMAN; LUNG SMALL CELL CANCER; MALE; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

AGED; CARCINOMA, SMALL CELL; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PROGNOSIS; TECHNETIUM TC 99M SESTAMIBI; THORAX; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0032127361     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19980701)83:1<64::AID-CNCR9>3.0.CO;2-E     Document Type: Article

References (20)

1. Smit EF, Postmus PE. Chemotherapy of small cell lung cancer. In: Carney DN, editor. Lung cancer. London: The Bath Press, Avon, 1995:156-72.
2. Berlin J, Schiller JH. Chemotherapy of small-cell carcinoma of the lung. In: Johnson BE, Johnson DH, editors. Lung cancer. New York: Wiley-Liss, 1995:247-61.
3. Lassen U, Hansen HH. Small cell carcinoma of the lung. In: Haskell CM, Berek JS, editors. Cancer treatment. Philadelphia: W.B. Saunders, 1995:414-20.
4. Kao CH, Wang SJ, Lin WY, Hsu CY, Liao SQ, Yeh SH. Differentiation of single solid lesions in the lungs by means of single-photon emission tomography with technetium-99m methoxyisobutylisonitrile. Eur J Nucl Med 1993;20:249-54.
5. Abdel-Dayem HM, Scott A, Macapinlac H, Larson S. Tracer imaging in lung cancer. Eur J Nucl Med 1994;21:57-81.
6. Cordobes MD, Starzec A, Delmon-Moingeon L, Blanchot C, Kouyoumadjian JC, Prevost G, et al. Technetium-99m-MIBI uptake by human benign and malignant breast tumor cells: correlation with mdr gene expression. J Nucl Med 1996;37: 286-9.
7. Piwnica-Worms D, Chiu ML, Budding M, Kronauge IF, Kramer RA, Croop JM. Functional imaging of multidrug-resistant P-glycoprotein with an organotechnetium complex. Cancer Res 1993;53:977-84.
8. Ballinger JR, Bannerman J, Boxen I, Firby P, Hartman NG, Moore MJ. Technetium-99m-tetrofosmin as a substrate for P-glycoprotein: in vitro studies in multidrug-resistant breast tumor cells. J Nucl Med 1996;37:1578-82.
9. Moretti JL, Caglar M, Boaziz C, Caillat-Vigneron N, Morere JF. Sequential functional imaging with technetium-99m hexakis-2-methoxyisobutylisonitrile and indium-111 octreotide: can we predict the response to chemotherapy in small cell lung cancer? Eur J Nucl Med 1995;22:177-80.
10. Derebek E, Kirkali Z, Dogan AS, Degirmenci B, Yilmaz M, Igci E, et al. Tc-99m-MIBI scintigraphy in metastatic renal cell carcinoma: clinical validation of the relationship between Tc-99m-MIBI uptake and P-glycoprotein expression in tumour tissue. Eur J Nucl Med 1996;23:976-9.
11. Moretti JL, Azaloux H, Boisseron D, Kouyoumdjian JC, Vilcoq J. Primary breast cancer imaging with technetium-99m sestamibi and its relation with P-glycoprotein overexpression. Eur J Nucl Med 1996;23:980-6.
12. Richardson GE, Ihde DC. Staging of small cell lung cancer. In: Carney DN, editor. Lung cancer. London: The Bath Press, Avon, 1995:114-27.
13. Aktolun C, Bayhan H, Pabuccu Y, Bilgic H, Acar H, Koylu R. Assessment of tumour necrosis and detection of mediastinal lymph node metastasis in bronchial carcinoma with technetium-99m MIBI imaging: comparison with CT scan. Eur J Nucl Med 1994;21:973-9.
14. Addis BJ. Pathology of lung cancer. In: Hoogastraten B, Addis BJ, Hansen HH, Martini N, Spiro SG, editors. Lung tumors. Berlin: Springer-Verlag, 1988:17-36.
15. Spiro SG. Prognosis and end results. In: Hoogastraten B, Addis BJ, Hansen HH, Martini N, Spiro SG, editors. Lung tumors. Berlin: Springer-Verlag, 1988:163-6.
16. Kao CH, Wang SJ, Liu TJ. The use of technetium-99m methoxyisobutylisonitrile breast scintigraphy to evaluate palpable breast masses. Eur J Nucl Med 1994;21:432-6.
17. Bom HS, Kim JY, Kim YC, Choi IS, Park KO. Tc-99m MIBI uptake in simultaneous thyroid and lung cancers. Clin Nucl Med 1994;19:604-6.
18. Hassan IM, Sahweil A, Constantinides C, Mahmoud A, Nair M, Omar YT, et al. Uptake and kinetics of Tc-99m hexakis 2-methoxy isobutyl isonitrile in benign and malignant lesions in the lungs. Clin Nucl Med 1989;14:333-40.
19. Chiu ML, Kronauge JF, Piwnica-Worms D. Effect of mitochondrial and plasma membrane potentials on accumulation of hexakis (2-methoxyisobutylisonitrile) technetium (I) in cultured mouse flbroblast. J Nucl Med 1990;31:1646-53.
20. Piwnica-Worms D, Holman BL. Noncardiac applications of hexakis(alkylsionitrile)technetium-99m complexes. J Nucl Med 1990;31:1166-7.